Ogilvy Cambridge is a healthcare-focused startup established in 1987 and headquartered in the United States. The company specializes in collaborating with a diverse range of clients, including global Fortune 500 companies, leading research and academic institutions, as well as professional and patient groups, all deeply involved in significant healthcare shifts. Their expertise encompasses various areas within the health industry, involving large global and emerging pharmaceutical, biopharmaceutical, health IT, diagnostic & device, and contract research companies, among others. Over the past 20+ years, Ogilvy Cambridge has developed comprehensive experience in multiple disease categories and stages of development and commercialization, as well as advanced and emerging areas of innovation such as genomics, proteomics, nanotechnology, and informatics-based solutions.
The company offers a wide array of services ranging from strategy, brand development, marketing, public affairs, media and advocacy relations, patient and professional education, corporate, pipeline and product communications, social media research and engagement, as well as issues management and risk communication. Despite its extensive profile and impressive client base, there is no record of its last investment or the involved investors yet.
Overall, Ogilvy Cambridge presents itself as a significant player in the healthcare sector, with a broad range of expertise, experience, and capabilities that position it as an appealing potential investment opportunity for venture capitalists keen on the health and life sciences industry.
